Published December 17, 2020
The medical device trade websites, Mass Device and Medical Design & Outsourcing, report that UB spinoff company Garwood Medical Devices has received a $749,000 federal grant to evaluate if its BioPrax medical device can prevent, control, and eliminate bacterial biofilm infections associated with orthopedic implants.
“We believe this novel infection-control strategy has the potential to introduce a paradigm shift in the treatment of orthopedic implant-associated infections (IAIs), as it would allow for effective treatment without having to remove the implant, thereby maintaining biomechanical stability and mobility of the body segment, and reducing the morbidity and mortality rates associated with recalcitrant IAIs,” says Mark Ehrensberger, co-inventor of the CVCES technology and associate professor in the Department of Biomedical Engineering.
Read the Mass Device and Medical Design & Outsourcing stories.
